Clinical cardioprotection and the value of conditioning responses

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 296, Issue 6, 2009, Pages

  Peart, Jason N ^a   Headrick, John P ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Acute myocardial infarction; Aging; Cardiac ischemia; Clinical translation; Diabetes; Obesity; Postconditioning; Preconditioning; Reperfusion

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTIRHEUMATIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; GLYCERYL TRINITRATE; IBUPROFEN; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; SULFONYLUREA;

ACUTE CORONARY SYNDROME; CALORIC RESTRICTION; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CONDITIONING; DIABETES MELLITUS; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; GROUPS BY AGE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; HYPERTENSION; HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE;

ANIMALS; CARDIOTONIC AGENTS; HEART DISEASES; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL;

EID: 66949145127     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00162.2009     Document Type: Review

References (244)

1. Abete P, Ferrara N, Cioppa A, Ferrara P, Bianco S, Calabrese C, Cacciatore F, Longobardi G, Rengo F. Preconditioning does not prevent postischemic dysfunction in aging heart. J Am Coll Cardiol 27: 1777-1786, 1996. (Pubitemid 26198034)
2. Abete P, Ferrara N, Cacciatore F, Madrid A, Bianco S, Calabrese C, Napoli C, Scognamiglio P, Bollella O, Cioppa A, Longobardi G, Rengo F. Angina-induced protection against myocardial infarction in adult and elderly patients: a loss of preconditioning mechanism in the aging heart? J Am Coll Cardiol 30: 947-954, 1997. (Pubitemid 27435886)
3. Abete P, Calabrese C, Ferrara N, Cioppa A, Pisanelli P, Cacciatore F, Longobardi G, Napoli C, Rengo F. Exercise training restores ischemic preconditioning in the aging heart. J Am Coll Cardiol 36: 643-650, 2000. (Pubitemid 30627418)
4. Abete P, Testa G, Ferrara N, De Santis D, Capaccio P, Viati L, Calabrese C, Cacciatore F, Longobardi G, Condorelli M, Napoli C, Rengo F. Cardioprotective effect of ischemic preconditioning is preserved in food-restricted senescent rats. Am J Physiol Heart Circ Physiol 282: H1978-H1987, 2002. (Pubitemid 34663003)
5. Abete P, Testa G, Galizia G, Mazzella F, Della Morte D, de Santis D, Calabrese C, Cacciatore F, Gargiulo G, Ferrara N, Rengo G, Sica V, Napoli C, Rengo F. Tandem action of exercise training and food restriction completely preserves ischemic preconditioning in the aging heart. Exp Gerontol 40: 43-50, 2005. (Pubitemid 40138745)
6. Akita Y, Otani H, Matsuhisa S, Kyoi S, Enoki C, Hattori R, Imamura H, Kamihata H, Kimura Y, Iwasaka T. Exercise-induced activation of cardiac sympathetic nerve triggers cardioprotection via redox-sensitive activation of eNOS and upregulation of iNOS. Am J Physiol Heart Circ Physiol 292: H2051-H2059, 2007. (Pubitemid 47084579)
7. Ali ZA, Callaghan CJ, Lim E, Ali AA, Nouraei SA, Akthar AM, Boyle JR, Varty K, Kharbanda RK, Dutka DP, Gaunt ME. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation 116: I98-I105, 2007. (Pubitemid 47480776)
8. Atalay M, Seene T, Hänninen O, Sen CK. Skeletal muscle and heart antioxidant defences in response to sprint training. Acta Physiol Scand 158: 129-134, 1996. (Pubitemid 26338711)
9. Aydin C, Ince E, Koparan S, Cangul IT, Naziroglu M, Ak F. Protective effects of long term dietary restriction on swimming exercise-induced oxidative stress in the liver, heart and kidney of rat. Cell Biochem Funct 25: 129-137, 2007. (Pubitemid 46408645)
10. Bae S, Zhang L. Gender differences in cardioprotection against ischemia/reperfusion injury in adult rat hearts: focus on Akt and protein kinase C signaling. J Pharmacol Exp Ther 315: 1125-1135, 2005. (Pubitemid 41635399)
11. Balluz L, Wen XJ, Town M, Shire JD, Qualter J, Mokdad A. Ischemic heart disease and ambient air pollution of particulate matter 2.5 in 51 counties in the US. Public Health Rep 122: 626-633, 2007.
12. Bartling B, Friedrich I, Silber RE, Simm A. Ischemic preconditioning is not cardioprotective in senescent human myocardium. Ann Thorac Surg 76: 105-111, 2003. (Pubitemid 36819725)
13. Benjamin IJ, Guo Y, Srinivasan S, Boudina S, Taylor RP, Rajasekaran NS, Gottlieb R, Wawrousek EF, Abel ED, Bolli R. CRYAB and HSPB2 deficiency alters cardiac metabolism and paradoxically confers protection against myocardial ischemia in aging mice. Am J Physiol Heart Circ Physiol 293: H3201-H3209, 2007. (Pubitemid 350106548)
14. Besse S, Tanguy S, Boucher F, Le Page C, Rozenberg S, Riou B, Leiris J, Swynghedauw B. Cardioprotection with cariporide, a sodium-proton exchanger inhibitor, after prolonged ischemia and reperfusion in senescent rats. Exp Gerontol 39: 1307-1314, 2004. (Pubitemid 39360371)
15. Boengler K, Buechert A, Heinen Y, Roeskes C, Hilfiker-Kleiner D, Heusch G, Schulz R. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res 102: 131-135, 2007.
16. Boengler K, Konietzka I, Buechert A, Heinen Y, Garcia-Dorado D, Heusch G, Schulz R. Loss of ischemic preconditioning's cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43. Am J Physiol Heart Circ Physiol 292: H1764-H1769, 2007. (Pubitemid 46572399)
17. Bolli R, Becker L, Gross G, Mentzer R Jr, Balshaw D, Lathrop DA; NHLBI Working Group on the Translation of Therapies for Protecting the Heart from Ischemia. Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res 95: 125-134, 2004.
18. Bouhidel O, Pons S, Souktani R, Zini R, Berdeaux A, Ghaleh B. Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice. Am J Physiol Heart Circ Physiol 295: H1580-H1586, 2008.
19. Broderick TL, Driedzic WR, Gillis M, Jacob J, Belke T. Effects of chronic food restriction and exercise training on the recovery of cardiac function following ischemia. J Gerontol A Biol Sci Med Sci 56: B33-B37, 2001. (Pubitemid 32042958)
20. Broderick TL, Belke T, Driedzic WR. Effects of chronic caloric restriction on mitochondrial respiration in the ischemic reperfused rat heart. Mol Cell Biochem 233: 119-125, 2002. (Pubitemid 34746117)
21. Brown DA, Lynch JM, Armstrong CJ, Caruso NM, Ehlers LB, Johnson MS, Moore RL. Susceptibility of the heart to ischaemia-reperfusion injury and exercise-induced cardioprotection are sex-dependent in the rat. J Physiol 564: 619-630, 2005. (Pubitemid 40585058)
22. ATP channel in the rat. J Physiol 569: 913-924, 2005.
23. Burns PG, Krunkenkamp IB, Calderone CA, Kirvaitis RJ, Gaudette GR, Levitsky S. Is the preconditioning response conserved in senescent myocardium? Ann Thorac Surg 61: 925-929, 1996. (Pubitemid 26084556)
24. Butler KL, Huang AH, Gwathmey JK. AT1-receptor blockade enhances ischemic preconditioning in hypertrophied rat myocardium. Am J Physiol Heart Circ Physiol 277: H2482-H2487, 1999. (Pubitemid 30048173)
25. Butler KL, Huffman LC, Koch SE, Hahn HS, Gwathmey JK. STAT-3 activation is necessary for ischemic preconditioning in hypertrophied myocardium. Am J Physiol Heart Circ Physiol 291: H797-H803, 2006. (Pubitemid 44175087)
26. 2+ channel blockade prevents ischemic preconditioning of human myocardium. J Mol Cell Cardiol 31: 2191-2197, 1999.
27. Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ, Gore JM, Weaver WD, Rogers WJ, Tiefenbrunn AJ. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 283: 2941-2947, 2000. (Pubitemid 30414505)
28. Carr CS, Yellon DM. Ischaemic preconditioning may abolish the protection afforded by ATP-sensitive potassium channel openers in isolated human atrial muscle. Basic Res Cardiol 92: 252-260, 1997. (Pubitemid 27443299)
29. Chakravarthy MV, Booth FW. Eating, exercise, and "thrifty" genotypes: connecting the dots toward an evolutionary understanding of modern chronic diseases. J Appl Physiol 96: 3-10, 2004. (Pubitemid 38035170)
30. Chandrasekar B, Nelson JF, Colston JT, Freeman GL. Calorie restriction attenuates inflammatory responses to myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 280: H2094-H2102, 2001. (Pubitemid 32433788)
31. Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, Holtby HM, Cox PN, Smallhorn JF, Van Arsdell GS, Redington AN. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 47: 2277-2282, 2006. (Pubitemid 43795071)
32. Clarke SJ, Khaliulin I, Das M, Parker JE, Heesom KJ, Halestrap AP. Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation. Circ Res 102: 1082-1090, 2008.
33. Cleveland JC Jr, Meldrum DR, Cain BS, Banerjee A, Harken AH. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited. Circulation 96: 29-32, 1997. (Pubitemid 27298399)
34. Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 295: 1135-1141, 2006. (Pubitemid 43352342)
35. Cornelussen RN, Garnier AV, Vork MM, Geurten P, Reneman RS, van der Vusse GJ, Snoeckx LH. Heat stress protects aged hypertrophied and nonhypertrophied rat hearts against ischemic damage. Am J Physiol Heart Circ Physiol 273: H1333-H1341, 1997. (Pubitemid 27418833)
36. Crandall DL, Feirer RP, Griffith DR, Beitz DC. Relative role of caloric restriction and exercise training upon susceptibility to isoproterenol- induced myocardial infarction in male rats. Am J Clin Nutr 34: 841-847, 1981. (Pubitemid 11077916)
37. Cremer J, Steinhoff G, Karck M, Ahnsell T, Brandt M, Teebken OE, Hollander D, Haverich A. Ischemic preconditioning prior to myocardial protection with cold blood cardioplegia in coronary surgery. Eur J Cardiothorac Surg 12: 753-1738, 1997. (Pubitemid 28035540)
38. Cremer J, Karck M, Ahnsel T, Steinhoff G, Brandt M, Hollander D, Teebken O, Zick G, Haverich A. Ischemic preconditioning as an adjunct to crystalloid or blood cardioplegia for myocardial protection in routine coronary surgery. Thorac Cardiovasc Surg 46: 298-301, 1998. (Pubitemid 128688190)
39. Csont T, Balogh G, Csonka C, Boros I, Horváth I, Vigh L, Ferdinandy P. Hyperlipidemia induced by high cholesterol diet inhibits heat shock response in rat hearts. Biochem Biophys Res Commun 290: 1535-1538, 2002. (Pubitemid 34687432)
40. Cutler JA. Calcium-channel blockers for hypertension-uncertainty continues. N Engl J Med 338: 679-681, 1998.
41. Darling CE, Solari PB, Smith CS, Furman MI, Przyklenk K. "Post-conditioning" the human heart: multiple balloon inflations during primary angioplasty may confer cardioprotection. Basic Res Cardiol 102: 274-278, 2007. (Pubitemid 46564075)
42. Del Valle HF, Lascano EC, Negroni JA. Ischemic preconditioning protection against stunning in conscious diabetic sheep: role of glucose, insulin, sarcolemmal and mitochondrial KATP channels. Cardiovasc Res 55: 642-659, 2002. (Pubitemid 34879091)
43. Del Valle HF, Lascano EC, Negroni JA, Crottogini AJ. Absence of ischemic preconditioning protection in diabetic sheep hearts: role of sarcolemmal KATP channel dysfunction. Mol Cell Biochem 249: 21-30, 2003. (Pubitemid 37021025)
44. Demirel HA, Powers SK, Zergeroglu MA, Shanely RA, Hamilton K, Coombes J, Naito H. Short-term exercise improves myocardial tolerance to in vivo ischemia-reperfusion in the rat. J Appl Physiol 91: 2205-2212, 2001. (Pubitemid 33015075)
45. Dickson EW, Hogrefe CP, Ludwig PS, Ackermann LW, Stoll LL, Denning GM. Exercise enhances myocardial ischemic tolerance via an opioid receptor-dependent mechanism. Am J Physiol Heart Circ Physiol 294: H402-H408, 2008.
46. Dobson GP, Jones MW. Adenosine and lidocaine: a new concept in nondepolarizing surgical myocardial arrest, protection, and preservation. J Thorac Cardiovasc Surg 127: 794-805, 2004. (Pubitemid 38316186)
47. Dow J, Bhandari A, Kloner RA. Ischemic postconditioning's benefit on reperfusion ventricular arrhythmias is maintained in the senescent heart. J Cardiovasc Pharmacol Ther 13: 141-148, 2008.
48. Downey JM, Davis AM, Cohen MV. Signaling pathways in ischemic preconditioning. Heart Fail Rev 12: 181-188, 2007. (Pubitemid 350176691)
49. Ebel D, Müllenheim J, Frässdorf J, Heinen A, Huhn R, Bohlen T, Ferrari J, Südkamp H, Preckel B, Schlack W, Thämer V. Effect of acute hyperglycaemia and diabetes mellitus with and without short-term insulin treatment on myocardial ischaemic late preconditioning in the rabbit heart in vivo. Pflügers Arch 446: 175-182, 2003. (Pubitemid 36683580)
50. Ebrahim Z, Yellon DM, Baxter GF. Ischemic preconditioning is lost in aging hypertensive rat heart: independent effects of aging and longstanding hypertension. Exp Gerontol 42: 807-814, 2007. (Pubitemid 47058862)
51. Ebrahim Z, Yellon DM, Baxter GF. Attenuated cardioprotective response to bradykinin, but not classical ischaemic preconditioning, in DOCA-salt hypertensive left ventricular hypertrophy. Pharmacol Res 55: 42-48, 2007. (Pubitemid 46108586)
52. Ellis SG, Henschke CI, Sandor T, Wynne J, Braunwald E, Kloner RA. Time course of functional and biochemical recovery of myocardium salvaged by reperfusion. J Am Coll Cardiol 1: 1047-1055, 1983.
53. Faris B, Peynet J, Wassef M, Bel A, Mouas C, Duriez M, Menasché P. Failure of preconditioning to improve postcardioplegia stunning of minimally infarcted hearts. Ann Thorac Surg 64: 1735-1741, 1997. (Pubitemid 28066547)
54. Feng J, Fischer G, Lucchinetti E, Zhu M, Bestmann L, Jegger D, Arras M, Pasch T, Perriard JC, Schaub MC, Zaugg M. Infarct-remodeled myocardium is receptive to protection by isoflurane postconditioning: role of protein kinase B/Akt signaling. Anesthesiology 104: 1004-1014, 2006. (Pubitemid 43755039)
55. Feng J, Lucchinetti E, Fischer G, Zhu M, Zaugg K, Schaub MC, Zaugg M. Cardiac remodelling hinders activation of cyclooxygenase-2, diminishing protection by delayed pharmacological preconditioning: role of HIF1 alpha and CREB. Cardiovasc Res 78: 98-107, 2008.
56. Fenton RA, Dickson EW, Meyer TE, Dobson JG Jr. Aging reduces the cardioprotective effect of ischemic preconditioning in the rat heart. J Mol Cell Cardiol 32: 1371-1375, 2000.
57. Fenton RA, Dickson EW, Dobson JG Jr. Inhibition of phosphatase activity enhances preconditioning and limits cell death in the ischemic/reperfused aged rat heart. Life Sci 77: 3375-3388, 2005. (Pubitemid 41434080)
58. Ferdinandy P, Szilvássy Z, Horváth LI, Csont T, Csonka C, Nagy E, Szentgyörgyi R, Nagy I, Koltai M, Dux L. Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet. J Mol Cell Cardiol 29: 3321-3333, 1997. (Pubitemid 28039366)
59. Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 59: 418-458, 2007.
60. Feuerstein G, Liu GL, Yue TL, Cheng HY, Hieble JP, Arch JR, Ruffolo RR Jr, Ma XL. Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model. Eur J Pharmacol 351: 341-350, 1998. (Pubitemid 28321470)
61. Friehs I, Stamm C, Cao-Danh H, McGowan FX, del Nido PJ. Insulin-like growth factor-1 improves postischemic recovery in hypertrophied hearts. Ann Thorac Surg 72: 1650-1656, 2001. (Pubitemid 33049780)
62. Gabel SA, Walker VR, London RE, Steenbergen C, Korach KS, Murphy E. Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury. J Mol Cell Cardiol 38: 289-297, 2005. (Pubitemid 40215198)
63. Garratt KN, Brady PA, Hassinger NL, Grill DE, Terzic A, Holmes DR Jr. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 33: 119-124, 1999. (Pubitemid 29064081)
64. Ghosh S, Galiñanes M. Protection of the human heart with ischemic preconditioning during cardiac surgery: role of cardiopulmonary bypass. J Thorac Cardiovasc Surg 126: 133-142, 2003. (Pubitemid 36909950)
65. Ghosh S, Standen NB, Galiñianes M. Failure to precondition pathological human myocardium. J Am Coll Cardiol 37: 711-718, 2001. (Pubitemid 32202434)
66. Giricz Z, Lalu MM, Csonka C, Bencsik P, Schulz R, Ferdinandy P. Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition. J Pharmacol Exp Ther 316: 154-161, 2006. (Pubitemid 41832592)
67. Gredilla R, Sanz A, Lopez-Torres M, Barja G. Caloric restriction decreases mitochondrial free radical generation at complex I and lowers oxidative damage to mitochondrial DNA in the rat heart. FASEB J 15: 1589-1591, 2001.
68. Greenland S. A meta-analysis of coffee, myocardial infarction, and coronary death. Epidemiology 4: 366-374, 1993. (Pubitemid 23199715)
69. Gross ER, Hsu AK, Gross GJ. Acute aspirin treatment abolishes, whereas acute ibuprofen treatment enhances morphine-induced cardioprotection: role of 12-lipoxygenase. J Pharmacol Exp Ther 310: 185-191, 2004. (Pubitemid 38812710)
70. Gross ER, Hsu AK, Gross GJ. Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3β. Diabetes 56: 127-136, 2007. (Pubitemid 46263123)
71. ATP channels and myocardial preconditioning: an update. Am J Physiol Heart Circ Physiol 285: H921-H930, 2003.
72. Günaydin B, Cakici I, Soncul H, Kalaycioglu S, Cevik C, Sancak B, Kanzik I, Karadenizli Y. Does remote organ ischaemia trigger cardiac preconditioning during coronary artery surgery? Pharmacol Res 41: 493-1436, 2000.
73. Gundewar S, Calvert JW, Elrod JW, Lefer DJ. Cytoprotective effects of N,N,N-trimethylsphingosine during ischemia- reperfusion injury are lost in the setting of obesity and diabetes. Am J Physiol Heart Circ Physiol 293: H2462-H2471, 2007. (Pubitemid 47605893)
74. Gysembergh A, Margonari H, Loufoua J, Ovize A, André-Fouët X, Minaire Y, Ovize M. Stretch-induced protection shares a common mechanism with ischemic preconditioning in rabbit heart. Am J Physiol Heart Circ Physiol 274: H955-H964, 1998. (Pubitemid 28158292)
75. Halestrap AP, Clarke SJ, Khaliulin I. The role of mitochondria in protection of the heart by preconditioning. Biochim Biophys Acta 1767: 1007-1031, 2007.
76. Hassouna A, Loubani M, Matata BM, Fowler A, Standen NB, Galiñanes M. Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium. Cardiovasc Res 69: 450-458, 2006. (Pubitemid 43098801)
77. Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: united at reperfusion. Pharmacol Ther 116: 173-191, 2007. (Pubitemid 47451505)
78. Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, Ashley E, Vichare S, Di Salvo C, Kolvekar S, Hayward M, Keogh B, MacAllister RJ, Yellon DM. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 370: 575-679, 2007. (Pubitemid 47247853)
79. Hausenloy DJ, Yellon DM. Clinical translation of cardioprotective strategies: report and recommendations of the Hatter Institute 5th International Workshop on Cardioprotection. Basic Res Cardiol 103: 493-500, 2008.
80. He Z, Crook JE, Meschia JF, Brott TG, Dickson DW, McKinney M. Aging blunts ischemic-preconditioning-induced neuroprotection following transient global ischemia in rats. Curr Neurovasc Res 2: 365-374, 2005. (Pubitemid 41789603)
81. Headrick JP, Willems L, Ashton KJ, Holmgren K, Peart J, Matherne GP. Ischaemic tolerance in aged mouse myocardium: the role of adenosine and effects of A1 adenosine receptor overexpression. J Physiol 549: 823-833, 2003. (Pubitemid 36889772)
82. 2+-sensitive potassium channel activation. Anesthesiology 109: 830-836, 2008.
83. Heusch G. Nitroglycerin and delayed preconditioning in humans: yet another new mechanism for an old drug? Circulation 103: 2876-2878, 2001. (Pubitemid 32578120)
84. 3 receptor activation in the normal and hypertrophied heart. Interact Cardiovasc Thorac Surg 6: 363-368, 2007.
85. Honma Y, Tani M, Takayama M, Yamamura K, Hasegawa H. Aging abolishes the cardioprotective effect of combination heat shock and hypoxic preconditioning in reperfused rat hearts. Basic Res Cardiol 97: 489-495, 2002. (Pubitemid 35373477)
86. Honma Y, Tani M, Yamamura K, Takayama M, Hasegawa H. Preconditioning with heat shock further improved functional recovery in young adult but not in middle-aged rat hearts. Exp Gerontol 38: 299-306, 2003. (Pubitemid 36170325)
87. Hoole SP, Heck PM, Sharples L, Khan SN, Duehmke R, Densem CG, Clarke SC, Shapiro LM, Schofield PM, O'Sullivan M, Dutka DP. Cardiac remote ischemic preconditioning in coronary stenting (CRISP Stent) study. a prospective, randomized control trial. Circulation 119: 820-827, 2009.
88. Hoshida S, Yamashita N, Igarashi J, Nishida M, Hori M, Kuzuya T, Tada M. A nitric oxide donor reverses myocardial injury in rabbits with acute hypercholesterolemia. J Pharmacol Exp Ther 278: 741-746, 1996. (Pubitemid 27167041)
89. Hu CP, Peng J, Xiao L, Ye F, Deng HW, Li YJ. Effect of age on alpha-calcitonin gene-related peptide-mediated delayed cardioprotection induced by intestinal preconditioning in rats. Regul Pept 107: 137-143, 2002. (Pubitemid 34876455)
90. Hueb W, Uchida AH, Gersh BJ, Betti RT, Lopes N, Moffa PJ, Ferreira BM, Ramires JA, Wajchenberg BL. Effect of a hypoglycemic agent on ischemic preconditioning in patients with type 2 diabetes and stable angina pectoris. Coron Artery Dis 18: 55-59, 2007. (Pubitemid 44973757)
91. Humphreys RA, Kane KA, Parratt JR. The influence of maturation and gender on the anti-arrhythmic effect of ischaemic preconditioning in rats. Basic Res Cardiol 94: 1-8, 1999. (Pubitemid 29103606)
92. Hunter JC, Kostyak JC, Novotny JL, Simpson AM, Korzick DH. Estrogen deficiency decreases ischemic tolerance in the aged rat heart: Roles of PKCδ, PKCε, Akt, and GSK3β. Am J Physiol Regul Integr Comp Physiol 292: R800-R809, 2007. (Pubitemid 46207733)
93. Iliodromitis EK, Zoga A, Vrettou A, Andreadou I, Paraskevaidis IA, Kaklamanis L, Kremastinos DT. The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis 188: 356-362, 2006. (Pubitemid 44313925)
94. Illes RW, Swoyer KD. Prospective, randomized clinical study of ischemic preconditioning as an adjunct to intermittent cold blood cardioplegia. Ann Thorac Surg 65: 748-752, 1998. (Pubitemid 28162473)
95. IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 359: 1269-1275, 2002. (Pubitemid 34310631)
96. Ishii H, Ichimiya S, Kanashiro M, Amano T, Imai K, Murohara T, Matsubara T. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation 112: 1284-1288, 2005. (Pubitemid 41266722)
97. Iwai T, Tanonaka K, Kasahara S, Inoue R, Takeo S. Protective effect of propranolol on mitochondrial function in the ischaemic heart. Br J Pharmacol 136: 472-480, 2002. (Pubitemid 34620528)
98. Jamnicki-Abegg M, Weihrauch D, Chiari PC, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR. Diabetes abolishes sildenafil-induced cGMP-dependent protein kinase-I expression and cardioprotection. J Cardiovasc Pharmacol 50: 670-676, 2007. (Pubitemid 350307037)
99. Jancso G, Cserepes B, Gasz B, Benko L, Ferencz A, Borsiczky B, Lantos J, Dureja A, Kiss K, Szeberényi J, Roth E. Effect of acetylsalicylic acid on nuclear factor-kappaB activation and on late preconditioning against infarction in the myocardium. J Cardiovasc Pharmacol 46: 295-301, 2005. (Pubitemid 41262831)
100. Jenkins DP, Pugsley WB, Alkhulaifi AM, Kemp M, Hooper J, Yellon DM. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 77: 314-318, 1997. (Pubitemid 27208169)
101. Ji B, Liu M, Liu J, Wang G, Feng W, Lu F, Shengshou H. Evaluation by cardiac troponin I: the effect of ischemic preconditioning as an adjunct to intermittent blood cardioplegia on coronary artery bypass grafting. J Card Surg 22: 394-400, 2007. (Pubitemid 47353016)
102. Ji LL, Gomez-Cabrera MC, Vina J. Exercise and hormesis: activation of cellular antioxidant signaling pathway. Ann NY Acad Sci 1067: 425-435, 2006. (Pubitemid 43806355)
103. Jneid H, Chandra M, Alshaher M, Hornung CA, Tang XL, Leesar M, Bolli R. Delayed preconditioning-mimetic actions of nitroglycerin in patients undergoing exercise tolerance tests. Circulation 111: 2565-2571, 2005. (Pubitemid 40740854)
104. Joyeux M, Faure P, Godin-Ribuot D, Halimi S, Patel A, Yellon DM, Demenge P, Ribuot C. Heat stress fails to protect myocardium of streptozotocin-induced diabetic rats against infarction. Cardiovasc Res 43: 939-946, 1999. (Pubitemid 29413193)
105. Jung O, Jung W, Malinski T, Wiemer G, Schoelkens BA, Linz W. Ischemic preconditioning and infarct mass: the effect of hypercholesterolemia and endothelial dysfunction. Clin Exp Hypertens 22: 165-179, 2000. (Pubitemid 30155433)
106. Katakam PV, Jordan JE, Snipes JA, Tulbert CD, Miller AW, Busija DW. Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance. Am J Physiol Regul Integr Comp Physiol 292: R920-R926, 2007. (Pubitemid 46207749)
107. Kavianipour M, Ronquist G, Wikström G, Waldenström A. Ischaemic preconditioning alters the energy metabolism and protects the ischaemic myocardium in a stepwise fashion. Acta Physiol Scand 178: 129-137, 2003. (Pubitemid 36718164)
108. Kawachi I, Colditz GA, Stone CB. Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. Br Heart J 72: 269-275, 1994. (Pubitemid 2122368)
109. Kehl F, Krolikowski JG, Weihrauch D, Pagel PS, Warltier DC, Kersten JR. N-acetylcysteine restores isoflurane-induced preconditioning against myocardial infarction during hyperglycemia. Anesthesiology 98: 1384-1390, 2003. (Pubitemid 36622471)
110. Kersten JR, Toller WG, Gross ER, Pagel PS, Warltier DC. Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am J Physiol Heart Circ Physiol 278: H1218-H1224, 2000. (Pubitemid 30235499)
111. Khanna S, Atalay M, Laaksonen DE, Gul M, Roy S, Sen CK. Alpha-lipoic acid supplementation: tissue glutathione homeostasis at rest and after exercise. J Appl Physiol 4: 1191-1196, 1999. (Pubitemid 29172151)
112. Kim JK, Pedram A, Razandi M, Levin ER. Estrogen prevents cardiomyocyte apoptosis through inhibition of reactive oxygen species and differential regulation of p38 kinase isoforms. J Biol Chem 281: 6760-6767, 2006. (Pubitemid 43847612)
113. Kitakaze M, Asakura M, Kim J, Shintani Y, Asanuma H, Hamasaki T, Seguchi O, Myoishi M, Minamino T, Ohara T, Nagai Y, Nanto S, Watanabe K, Fukuzawa S, Hirayama A, Nakamura N, Kimura K, Fujii K, Ishihara M, Saito Y, Tomoike H, Kitamura S; JWIND Investigators. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet 370: 1483-1493, 2007. (Pubitemid 47625560)
114. Klepzig H, Kober G, Matter C, Luus H, Schneider H, Boedeker KH, Kiowski W, Amann FW, Gruber D, Harris S, Burger W. Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide. Eur Heart J 20: 439-446, 1999. (Pubitemid 29116540)
115. Kloner RA, Rezkalla SH. Cardiac protection during acute myocardial infarction: where do we stand in 2004? J Am Coll Cardiol 44: 276-286, 2004. (Pubitemid 38950583)
116. Kloner RA, Forman MB, Gibbons RJ, Ross AM, Alexander RW, Stone GW. Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial. Eur Heart J 27: 2400-2405, 2006. (Pubitemid 44522145)
117. Kocić I, Konstański Z, Kaminski M, Dworakowska D, Dworakowski R. Experimental hyperlipidemia prevents the protective effect of ischemic preconditioning on the contractility and responsiveness to phenylephrine of rat-isolated stunned papillary muscle. Gen Pharmacol 33: 213-219, 1999. (Pubitemid 29376458)
118. Kolocassides KG, Seymour AM, Galinanes M, Hearse DJ. Paradoxical effect of ischemic preconditioning on ischemic contracture? NMR studies of energy metabolism and intracellular pH in the rat heart. J Mol Cell Cardiol 28: 1045-1057, 1996. (Pubitemid 26169310)
119. Korzick DH, Kostyak JC, Hunter JC, Saupe KW. Local delivery of PKCε-activating peptide mimics ischemic preconditioning in aged hearts through GSK-3β but not F1-ATPase inactivation. Am J Physiol Heart Circ Physiol 293: H2056-H2063, 2007. (Pubitemid 47605841)
120. Kostyak JC, Hunter JC, Korzick DH. Acute PKCδ inhibition limits ischaemia-reperfusion injury in the aged rat heart: role of GSK-3β. Cardiovasc Res 70: 325-334, 2006.
121. Kremastinos DT, Bofilis E, Karavolias GK, Papalois A, Kaklamanis L, Iliodromitis EK. Preconditioning limits myocardial infarct size in hypercholesterolemic rabbits. Atherosclerosis 150: 81-89, 2000.
122. Kristiansen SB, Løfgren B, Støttrup NB, Khatir D, Nielsen-Kudsk JE, Nielsen TT, Bøtker HE, Flyvbjerg A. Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes. Diabetologia 47: 1716-1721, 2004. (Pubitemid 40022406)
123. Kristo G, Yoshimura Y, Keith BJ, Mentzer RM Jr, Lasley RD. Aged rat myocardium exhibits normal adenosine receptor-mediated bradycardia and coronary vasodilation but increased adenosine agonist-mediated cardioprotection. J Gerontol A Biol Sci Med Sci 60: 1399-1404, 2005. (Pubitemid 41798446)
124. Kyriakides ZS, Psychari S, Iliodromitis EK, Kolettis TM, Sbarouni E, Kremastinos DT. Hyperlipidemia prevents the expected reduction of myocardial ischemia on repeated balloon inflations during angioplasty. Chest 121:
125. Laskey WK, Yoon S, Calzada N, Ricciardi MJ. Concordant improvements in coronary flow reserve and ST-segment resolution during percutaneous coronary intervention for acute myocardial infarction: a benefit of postconditioning. Catheter Cardiovasc Interv 72: 212-220, 2008.
126. Lauzier B, Delemasure S, Debin R, Collin B, Sicard P, Acar N, Bretillon L, Joffre C, Bron A, Creuzot-Garcher C, Vergely C, Rochette L. Beneficial effects of myocardial postconditioning are associated with reduced oxidative stress in a senescent mouse model. Transplantation 85: 1802-1808, 2008.
127. Lee TM, Chou TF. Impairment of myocardial protection in type 2 diabetic patients. J Clin Endocrinol Metab 88: 531-537, 2003. (Pubitemid 36207785)
128. Lee TM, Su SF, Chou TF, Lee YT, Tsai CH. Loss of preconditioning by attenuated activation of myocardial ATP-sensitive potassium channels in elderly patients undergoing coronary angioplasty. Circulation 105: 334-340, 2002. (Pubitemid 34106182)
129. Lee CK, Allison DB, Brand J, Weindruch R, Prolla TA. Transcriptional profiles associated with aging and middle age-onset caloric restriction in mouse hearts. Proc Natl Acad Sci USA 99: 14988-14993, 2002. (Pubitemid 35334597)
130. Lee PY, Alexander KP, Hammill BG, Pasquali SK, Peterson ED. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 286: 708-713, 2001.
131. Leesar MA, Stoddard MF, Dawn B, Jasti VG, Masden R, Bolli R. Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Circulation 103: 2935-2941, 2001. (Pubitemid 32578131)
132. Li G, Tokuno S, Tähep Id P, Vaage J, Löwbeer C, Valen G. Preconditioning protects the severely atherosclerotic mouse heart. Ann Thorac Surg 71: 1296-1303, 2001. (Pubitemid 32331371)
133. Liu J, Yeo HC, Overvik-Douki E, Hagen T, Doniger SJ, Chyu DW, Brooks GA, Ames BN. Chronically and acutely exercised rats: biomarkers of oxidative stress and endogenous antioxidants. J Appl Physiol 89: 21-28, 2000. (Pubitemid 30482559)
134. Locke M, Tanguay RM, Klabunde RE, Ianuzzo CD. Enhanced post-ischemic myocardial recovery following exercise induction of HSP 72. Am J Physiol Heart Circ Physiol 269: H320-H325, 1995.
135. Long P, Nguyen Q, Thurow C, Broderick TL. Caloric restriction restores the cardioprotective effect of preconditioning in the rat heart. Mech Ageing Dev 123: 1411-1413, 2002. (Pubitemid 35247436)
136. Longobardi G, Abete P, Ferrara N, Papa A, Rosiello R, Furgi G, Calabrese C, Cacciatore F, Rengo F. "Warm-up" phenomenon in adult and elderly patients with coronary artery disease: further evidence of the loss of "ischemic preconditioning" in the aging heart. J Gerontol A Biol Sci Med Sci 55: M124-M129, 2000. (Pubitemid 30243731)
137. López-Torres M, Gredilla R, Sanz A, Barja G. Influence of aging and long-term caloric restriction on oxygen radical generation and oxidative DNA damage in rat liver mitochondria. Free Radic Biol Med 32: 882-889, 2002. (Pubitemid 34439258)
138. Loubani M, Ghosh S, Galiñanes M. The aging human myocardium: tolerance to ischemia and responsiveness to ischemic preconditioning. J Thorac Cardiovasc Surg 126: 143-147, 2003. (Pubitemid 36909951)
139. Lu EX, Chen SX, Yuan MD, Hu TH, Zhou HC, Luo WJ, Li GH, Xu LM. Preconditioning improves myocardial preservation in patients undergoing open heart operations. Ann Thorac Surg 64: 1320-1324, 1997. (Pubitemid 27522626)
140. Lu R, Hu CP, Deng HW, Li YJ. Calcitonin gene-related peptide-mediated ischemic preconditioning in the rat heart: influence of age. Regul Pept 99: 183-189, 2001. (Pubitemid 32522546)
141. Lu R, Hu CP, Peng J, Deng HW, Li YJ. Role of calcitonin gene-related peptide in ischaemic preconditioning in diabetic rat hearts. Clin Exp Pharmacol Physiol 28: 392-396, 2001. (Pubitemid 32538905)
142. Lucchinetti E, Jamnicki M, Fischer G, Zaugg M. Preconditioning by isoflurane retains its protection against ischemia-reperfusion injury in postinfarct remodeled rat hearts. Anesth Analg 106: 17-23, 2008.
143. Ma X, Zhang X, Li C, Luo M. Effect of postconditioning on coronary blood flow velocity and endothelial function and LV recovery after myocardial infarction. J Interv Cardiol 19: 367-375, 2006. (Pubitemid 44511065)
144. Marinovic J, Ljubkovic M, Stadnicka A, Bosnjak ZJ, Bienengraeber M. Role of sarcolemmal ATP-sensitive potassium channel in oxidative stress-induced apoptosis: mitochondrial connection. Am J Physiol Heart Circ Physiol 294: H1317-H1325, 2008.
145. Maroko PR, Kjekshus JK, Sobel BE, Watanabe T, Covell JW, Ross J Jr, Braunwald E. Factors influencing infarct size following experimental coronary artery occlusions. Circulation 43: 67-82, 1971.
146. Masternak MM, Al-Regaiey KA,. Del Rosario Lim MM, Jimenez-Ortega V, Panici JA, Bonkowski MS, Kopchick JJ, Wang Z, Bartke A. Caloric restriction and growth hormone receptor knockout: effects on expression of genes involved in insulin action in the heart. Exp Gerontol 41: 417-429, 2006.
147. Matyal R. Newly appreciated pathophysiology of ischemic heart disease in women mandates changes in perioperative management: a core review. Anesth Analg 107: 37-50, 2008.
148. McCully JD, Toyoda Y, Wakiyama H, Rousou AJ, Parker RA, Levitsky S. Age- and gender-related differences in ischemia/reperfusion injury and cardioprotection: effects of diazoxide. Ann Thorac Surg 82: 117-123, 2006. (Pubitemid 43913649)
149. McCully JD, Rousou AJ, Parker RA, Levitsky S. Age- and gender-related differences in mitochondrial oxygen consumption and calcium with cardioplegia and diazoxide. Ann Thorac Surg 83: 1102-1109, 2007. (Pubitemid 46328830)
150. Miki T, Miura T, Tsuchida A, Nakano A, Hasegawa T, Fukuma T, Shimamoto K. Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation. Circulation 102: 458-463, 2000. (Pubitemid 30490686)
151. Mio Y, Bienengraeber MW, Marinovic J, Gutterman DD, Rakic M, Bosnjak ZJ, Stadnicka A. Age-related attenuation of isoflurane preconditioning in human atrial cardiomyocytes: roles for mitochondrial respiration and sarcolemmal adenosine triphosphate-sensitive potassium channel activity. Anesthesiology 108: 612-620, 2008.
152. Miura T, Miki T. Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapy. Basic Res Cardiol 103: 501-513, 2008.
153. Moolman JA, Genade S, Tromp E, Opie LH, Lochner A. Ischaemic preconditioning does not protect hypertrophied myocardium against ischaemia. S Afr Med J 87, Suppl 3: C151-C156, 1997. (Pubitemid 27448694)
154. Murphy E, Steenbergen C. Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. Cardiovasc Res 75: 478-486, 2007. (Pubitemid 47080962)
155. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986. (Pubitemid 17174962)
156. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346: 793-801, 2000.
157. Nakagawa C, Asayama J, Katamura M, Matoba S, Keira N, Kawahara A, Tsuruyama K, Tanaka T, Kobara M, Akashi K, Ohta B, Tatsumi T, Nakagawa M. Myocardial stretch induced by increased left ventricular diastolic pressure preconditions isolated perfused hearts of normotensive and spontaneously hypertensive rats. Basic Res Cardiol 92: 410-416, 1997. (Pubitemid 28018080)
158. + exchanger inhibitor HOE642 offers myoprotection in senescent myocardium independent of ischemic preconditioning mechanisms. Eur Surg Res 34: 244-250, 2002.
159. Napoli C, Liguori A, Cacciatore F, Rengo F, Ambrosio G, Abete P. "Warm-up" phenomenon detected by electrocardiographic ambulatory monitoring in adult and older patients. J Am Geriatr Soc 47: 1114-1117, 1999. (Pubitemid 29420620)
160. Niccoli G, Altamura L, Fabretti A, Lanza GA, Biasucci LM, Rebuzzi AG, Leone AM, Porto I, Burzotta F, Trani C, Crea F. Ethanol abolishes ischemic preconditioning in humans. J Am Coll Cardiol 51: 271-275, 2008.
161. Ohkuwa T, Sato Y, Naoi M. Glutathione status and reactive oxygen generation in tissues of young and old exercised rats. Acta Physiol Scand 3: 237-244, 1997. (Pubitemid 27104510)
162. Pantos CI, Davos CH, Carageorgiou HC, Varonos DV, Cokkinos DV. Ischaemic preconditioning protects against myocardial dysfunction caused by ischaemia in isolated hypertrophied rat hearts. Basic Res Cardiol 91: 444-449, 1996. (Pubitemid 27022797)
163. Park SC. New molecular target for modulation of aging process. Antioxid Redox Signal 8: 620-627, 2006. (Pubitemid 43741330)
164. Peart JN, Gross GJ. Chronic exposure to morphine produces a marked cardioprotective phenotype in aged mouse hearts. Exp Gerontol 39: 1021-1026, 2004. (Pubitemid 38952882)
165. Peart JN, Gross ER, Headrick JP, Gross GJ. Impaired p38 MAPK/HSP27 signaling underlies aging-related failure in opioid-mediated cardioprotection. J Mol Cell Cardiol 42: 972-980, 2007. (Pubitemid 46678033)
166. Peart J, Willems L, Headrick JP. Receptor and non-receptor-dependent mechanisms of cardioprotection with adenosine. Am J Physiol Heart Circ Physiol 284: H519-H527, 2003. (Pubitemid 36142878)
167. Pêgo-Fernandes PM, Jatene FB, Kwasnicka K, Hueb AC, Moreira LF, Gentil AF, Stolf NA, Oliveira SA. Ischemic preconditioning in myocardial revascularization with intermittent aortic cross-clamping. J Card Surg 15: 333-338, 2000. (Pubitemid 32977028)
168. Penna C, Tullio F, Merlino A, Moro F, Raimondo S, Rastaldo R, Perrelli MG, Mancardi D, Pagliaro P. Postconditioning cardioprotection against infarct size and post-ischemic systolic dysfunction is influenced by gender. Basic Res Cardiol. 2008 Nov 22. [Epub ahead of print]
169. Penson PE, Ford WR, Kidd EJ, Broadley KJ. Activation of beta-adrenoceptors mimics preconditioning of rat-isolated atria and ventricles against ischaemic contractile dysfunction. Naunyn Schmiedebergs Arch Pharmacol 378: 589-597, 2008.
170. Perrault LP, Menasché P, Bel A, de Chaumaray T, Peynet J, Mondry A, Olivero P, Emanoil-Ravier R, Moalic JM. Ischemic preconditioning in cardiac surgery: a word of caution. J Thorac Cardiovasc Surg 112: 1378-1386, 1996. (Pubitemid 26403438)
171. 2b receptor cascade. Cardiovasc Res 70: 308-314, 2006.
172. Przyklenk K, Li G, Simkhovich BZ, Kloner RA. Mechanisms of myocardial ischemic preconditioning are age related: PKC-ε does not play a requisite role in old rabbits. J Appl Physiol 95: 2563-2569, 2003. (Pubitemid 37445003)
173. Przyklenk K, Whittaker P. In vitro platelet responsiveness to adenosine-mediated "preconditioning" is age-dependent. J Thromb Thrombolysis 19: 5-10, 2005.
174. Przyklenk K, Maynard M, Darling CE, Whittaker P. Aging mouse hearts are refractory to infarct size reduction with post-conditioning. J Am Coll Cardiol 51: 1393-1398, 2008.
175. Qi JS, Kam KW, Chen M, Wu S, Wong TM. Failure to confer cardioprotection and to increase the expression of heat-shock protein 70 by preconditioning with a κ-opioid receptor agonist during ischaemia and reperfusion in streptozotocin-induced diabetic rats. Diabetologia 47: 214-220, 2004. (Pubitemid 38315357)
176. Quindry JC, Hamilton KL, French JP, Lee Y, Murlasits Z, Tumer N, Powers SK. Exercise-induced HSP-72 elevation and cardioprotection against infarct and apoptosis. J Appl Physiol 103: 1056-1062, 2007. (Pubitemid 47358893)
177. Quinlan CL, Costa AD, Costa CL, Pierre SV, Dos Santos P, Garlid KD. Conditioning the heart induces formation of signalosomes that interact with mitochondria to open mitoKATP channels. Am J Physiol Heart Circ Physiol 295: H953-H961, 2008.
178. Randall MD, Gardiner SM, Bennett T. Enhanced cardiac preconditioning in the isolated heart of the transgenic [(mREN-2)27] hypertensive rat. Cardiovasc Res 33: 400-409, 1997. (Pubitemid 27072646)
179. Riess ML, Camara AK, Rhodes SS, McCormick J, Jiang MT, Stowe DF. Increasing heart size and age attenuate anesthetic preconditioning in guinea pig isolated hearts. Anesth Analg 101: 1572-1576, 2005. (Pubitemid 41720599)
180. Riksen NP, Zhou Z, Oyen WJ, Jaspers R, Ramakers BP, Brouwer RM, Boerman OC, Steinmetz N, Smits P, Rongen GA. Caffeine prevents protection in two human models of ischemic preconditioning. J Am Coll Cardiol 48: 700-707, 2006. (Pubitemid 44175737)
181. Rose'Meyer RB, Headrick JP, Peart JN, Harrison GJ, Garnham BG, Willis RJ. Acute but not chronic caffeine impairs functional responses to ischaemia-reperfusion in rat isolated perfused heart. Clin Exp Pharmacol Physiol 28: 19-24, 2001. (Pubitemid 32039553)
182. Ross AM, Gibbons RJ, Stone GW, Kloner RA, Alexander RW; AMISTADII Investigators. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 45: 1775-1780, 2005. (Pubitemid 40779856)
183. Samuel SM, Thirunavukkarasu M, Penumathsa SV, Paul D, Maulik N. Akt/FOXO3a/ SIRT1-mediated cardioprotection by n-tyrosol against ischemic stress in rat in vivo model of myocardial infarction: switching gears toward survival and longevity. J Agric Food Chem 56: 9692-9698, 2008.
184. Schaller BJ. Influence of age on stroke and preconditioning-induced ischemic tolerance in the brain. Exp Neurol 205: 9-19, 2007. (Pubitemid 46617487)
185. Schiesser M, Wittert A, Nieuwenhuijs VB, Morphett A, Padbury RT, Barritt GJ. Intermittent ischemia but not ischemic preconditioning is effective in restoring bile flow after ischemia reperfusion injury in the livers of aged rats. J Surg Res 2008 Feb 1. [Epub ahead of print]
186. Schulman D, Latchman DS, Yellon DM. Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 281: H1630-H1636, 2001. (Pubitemid 32948208)
187. Schulz R, Post H, Vahlhaus C, Heusch G. Ischemic preconditioning in pigs: a graded phenomenon: its relation to adenosine and bradykinin. Circulation 98: 1022-1029, 1998. (Pubitemid 28446656)
188. Schulz R, Boengler K, Totzeck A, Luo Y, Garcia-Dorado D, Heusch G. Connexin 43 in ischemic pre- and postconditioning. Heart Fail Rev 12: 261-266, 2007. (Pubitemid 350176699)
189. Scognamiglio R, Avogaro A, Vigili de Kreutzenberg S, Negut C, Palisi M, Bagolin E, Tiengo A. Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes. Diabetes 51: 808-812, 2002. (Pubitemid 34760193)
190. Selzner M, Selzner N, Jochum W, Graf R, Clavien PA. Increased ischemic injury in old mouse liver: an ATP-dependent mechanism. Liver Transpl 13: 382-390, 2007. (Pubitemid 46444467)
191. Shaw LJ, Bairey Merz CN, Pepine CJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Mankad S, Sharaf BL, Rogers WJ, Wessel TR, Arant CB, Pohost GM, Lerman A, Quyyumi AA, Sopko G; WISE Investigators. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 47, Suppl 3: S4-S20, 2006. (Pubitemid 43170826)
192. Shinmura K, Kodani E, Xuan YT, Dawn B, Tang XL, Bolli R. Effect of aspirin on late preconditioning against myocardial stunning in conscious rabbits. J Am Coll Cardiol 41: 1183-1194, 2003. (Pubitemid 36384907)
193. Shinmura K, Nagai M, Tamaki K, Bolli R. Gender and aging do not impair opioid-induced late preconditioning in rats. Basic Res Cardiol 99: 46-55, 2004. (Pubitemid 38049139)
194. + channels in both young and aged hearts. J Mol Cell Cardiol 39: 285-296, 2005.
195. Shinmura K, Tamaki K, Saito K, Nakano Y, Tobe T, Bolli R. Cardioprotective effects of short-term caloric restriction are mediated by adiponectin via activation of AMP-activated protein kinase. Circulation 116: 2809-2817, 2007. (Pubitemid 350291223)
196. Shinmura K, Tamaki K, Bolli R. Impact of 6-mo caloric restriction on myocardial ischemic tolerance: possible involvement of nitric oxide-dependent increase in nuclear Sirt1. Am J Physiol Heart Circ Physiol 295: H2348-H2355, 2008.
197. Sniecinski R, Liu H. Reduced efficacy of volatile anesthetic preconditioning with advanced age in isolated rat myocardium. Anesthesiology 100: 589-597, 2004. (Pubitemid 38268877)
198. Speechly-Dick ME, Baxter GF, Yellon DM. Ischaemic preconditioning protects hypertrophied myocardium. Cardiovasc Res 28: 1025-1029, 1994. (Pubitemid 24232558)
199. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, Aupetit JF, Bonnefoy E, Finet G, André-Fouët X, Ovize M. Postconditioning the human heart. Circulation 112: 2143-2148, 2005. (Pubitemid 41475808)
200. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 343: 16-22, 2000. (Pubitemid 30447987)
201. Starnes JW, Taylor RP. Exercise-induced cardioprotection: endogenous mechanisms. Med Sci Sports Exerc 39: 1537-1543, 2007. (Pubitemid 47360977)
202. Starnes JW, Taylor RP, Park Y. Exercise improves postischemic function in aging hearts. Am J Physiol Heart Circ Physiol 285: H347-H351, 2003. (Pubitemid 36736448)
203. Suematsu Y, Anttila V, Takamoto S, del Nido P. Cardioprotection afforded by ischemic preconditioning interferes with chronic beta-blocker treatment. Scand Cardiovasc J 38: 293-299, 2004. (Pubitemid 39462160)
204. Sui X, LaMonte MJ, Laditka JN, Hardin JW, Chase N, Hooker SP, Blair SN. Cardiorespiratory fitness and adiposity as mortality predictors in older adults. JAMA 298: 2507-2516, 2007. (Pubitemid 350223537)
205. 2+ channel α1 subunit and reduced ischemia/reperfusion injury. Circ Res 98: 403-411, 2006.
206. Szilvássy Z, Ferdinandy P, Szilvássy J, Nagy I, Karcsu S, Lonovics J, Dux L, Koltai M. The loss of pacing-induced preconditioning in atherosclerotic rabbits: role of hypercholesterolaemia. J Mol Cell Cardiol 27: 2559-2569, 1995. (Pubitemid 26003185)
207. Szmagala P, Morawski W, Krejca M, Gburek T, Bochenek A. Evaluation of perioperative myocardial tissue damage in ischemically preconditioned human heart during aorto coronary bypass surgery. J Cardiovasc Surg (Torino) 39: 791-795, 1998. (Pubitemid 29050349)
208. Takayama M, Ebihara Y, Tani M. Differences in the expression of protein kinase C isoforms and its translocation after stimulation with phorbol ester between young-adult and middle-aged ventricular cardiomyocytes isolated from Fischer 344 rats. Jpn Circ J 65: 1071-1076, 2001. (Pubitemid 33126520)
209. Tanaka K, Kehl F, Gu W, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR. Isoflurane-induced preconditioning is attenuated by diabetes. Am J Physiol Heart Circ Physiol 282: H2018-H2023, 2002. (Pubitemid 34663008)
210. Tani M, Suganuma Y, Hasegawa H, Shinmura K, Hayashi Y, Guo X, Nakamura Y. Changes in ischemic tolerance and effects of ischemic preconditioning in middle-aged rat hearts. Circulation 95: 2559-2566, 1997. (Pubitemid 27233122)
211. Tani M, Honma Y, Takayama M, Hasegawa H, Shinmura K, Ebihara Y, Tamaki K. Loss of protection by hypoxic preconditioning in aging Fischer 344 rat hearts related to myocardial glycogen content and Na+ imbalance. Cardiovasc Res 41: 594-602, 1999. (Pubitemid 29130623)
212. ATP channels mimics preconditioning but protein kinase C activation is less effective in middle-aged rat hearts. Cardiovasc Res 49: 56-68, 2001.
213. Taylor RP, Olsen ME, Starnes JW. Improved postischemic function following acute exercise is not mediated by nitric oxide synthase in the rat heart. Am J Physiol Heart Circ Physiol 292: H601-H607, 2007. (Pubitemid 46115926)
214. Teoh LK, Grant R, Hulf JA, Pugsley WB, Yellon DM. The effect of preconditioning [ischemic and pharmacological] on myocardial necrosis following coronary artery bypass graft surgery. Cardiovasc Res 53: 175-180, 2002. (Pubitemid 34020778)
215. Teoh LK, Grant R, Hulf JA, Pugsley WB, Yellon DM. A comparison between ischemic preconditioning, intermittent cross-clamp fibrillation and cold crystalloid cardioplegia for myocardial protection during coronary artery bypass graft surgery. Cardiovasc Surg 10: 251-255, 2002. (Pubitemid 34606980)
216. Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G, Cung TT, Bonnefoy E, Angoulvant D, Aupetit JF, Finet G, André-Fouët X, Macia JC, Raczka F, Rossi R, Itti R, Kirkorian G, Derumeaux G, Ovize M. Long-term benefit of postconditioning. Circulation 117: 1037-1044, 2008.
217. Tomai F, Crea F, Gaspardone A, Versaci F, Ghini AS, De Paulis R, Chiariello L, Gioffrè PA. Phentolamine prevents adaptation to ischemia during coronary angioplasty: role of α-adrenergic receptors in ischemic preconditioning. Circulation 96: 2171-2177, 1997. (Pubitemid 27425819)
218. Tosaki A, Engelman DT, Engelman RM, Das DK. The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts. Cardiovasc Res 31: 526-536, 1996. (Pubitemid 26140063)
219. Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM. Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes 54: 2360-2364, 2005. (Pubitemid 41134263)
220. Turcato S, Turnbull L, Wang GY, Honbo N, Simpson PC, Karliner JS, Baker AJ. Ischemic preconditioning depends on age and gender. Basic Res Cardiol 101: 235-243, 2006.
221. Ueda Y, Kitakaze M, Komamura K, Minamino T, Asanuma H, Sato H, Kuzuya T, Takeda H, Hori M. Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction. J Am Coll Cardiol 34: 2120-2125, 1999. (Pubitemid 30002674)
222. Ungi I, Ungi T, Ruzsa Z, Nagy E, Zimmermann Z, Csont T, Ferdinandy P. Hypercholesterolemia attenuates the anti-ischemic effect of preconditioning during coronary angioplasty. Chest 128: 1623-1628, 2005. (Pubitemid 41324456)
223. Vigh L, Maresca B, Harwood JL. Does the membrane's physical state control the expression of heat shock and other genes? Trends Biochem Sci 23: 369-374, 1998. (Pubitemid 28511372)
224. Wagner C, Kloeting I, Strasser RH, Weinbrenner C. Cardioprotection by postconditioning is lost in WOKW rats with metabolic syndrome: role of glycogen synthase kinase 3beta. J Cardiovasc Pharmacol 52: 430-437, 2008.
225. Walker DM, Walker JM, Pugsley WB, Pattison CW, Yellon DM. Preconditioning in isolated superfused human muscle. J Mol Cell Cardiol 27: 1349-1357, 1995.
226. 6-(2,5-dichlorobenzyl)-3′-aminoadenosine-5′-N- methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel. J Pharmacol Exp Ther 324: 234-243, 2008.
227. Wang TD, Chen WJ, Mau TJ, Lin JW, Lin WW, Lee YT. Attenuation of increased myocardial ischaemia-reperfusion injury conferred by hypercholesterolaemia through pharmacological inhibition of the caspase-1 cascade. Br J Pharmacol 138: 291-300, 2003. (Pubitemid 36188590)
228. Wang C, Chiari PC, Weihrauch D, Krolikowski JG, Warltier DC, Kersten JR, Pratt PF Jr, Pagel PS. Gender-specificity of delayed preconditioning by isoflurane in rabbits: potential role of endothelial nitric oxide synthase. Anesth Analg 103: 274-280, 2006. (Pubitemid 44140620)
229. Wang M, Crisostomo PR, Markel T, Wang Y, Lillemoe KD, Meldrum DR. Estrogen receptor beta mediates acute myocardial protection following ischemia. Surgery 144: 233-238, 2008.
230. Willems L, Zatta A, Holmgren K, Ashton KJ, Headrick JP. Age-related changes in ischemic tolerance in male and female mouse hearts. J Mol Cell Cardiol 38: 245-256, 2005. (Pubitemid 40215194)
231. Willems L, Ashton KJ, Headrick JP. Adenosine-mediated cardioprotection in the aging myocardium. Cardiovasc Res 66: 245-255, 2005. (Pubitemid 40471039)
232. Williams SC, Schmaltz SP, Morton DJ, Koss RG, Loeb JM. Quality of care in US hospitals as reflected by standardized measures, 2002-2004. N Engl J Med 353: 255-264, 2005.
233. Wu ZK, Tarkka MR, Pehkonen E, Kaukinen L, Honkonen EL, Kaukinen S. Ischaemic preconditioning has a beneficial effect on left ventricular haemodynamic function after a coronary artery biopass grafting operation. Scand Cardiovasc J 34: 247-253, 2000.
234. Wu ZK, Pehkonen E, Laurikka J, Kaukinen L, Honkonen EL, Kaukinen S, Tarkka MR. Ischemic preconditioning protects right ventricular function in coronary artery bypass grafting patients experiencing angina within 48-72 hours. J Cardiovasc Surg (Torino) 43: 319-326, 2002. (Pubitemid 34752527)
235. Wu ZK, Tarkka MR, Eloranta J, Pehkonen E, Laurikka J, Kaukinen L, Honkonen EL, Vuolle M, Kaukinen S. Effect of ischaemic preconditioning, cardiopulmonary bypass and myocardial ischaemic/reperfusion on free radical generation in CABG patients. Cardiovasc Surg 9: 362-368, 2001. (Pubitemid 32551927)
236. Wu ZK, Iivainen T, Pehkonen E, Laurikka J, Tarkka MR. Ischemic preconditioning suppresses ventricular tachyarrhythmias after myocardial revascularization. Circulation 106: 3091-3096, 2002. (Pubitemid 35440294)
237. Yang XC, Liu Y, Wang LF, Cui L, Wang T, Ge YG, Wang HS, Li WM, Xu L, Ni ZH, Liu SH, Zhang L, Jia HM, Vinten-Johansen J, Zhao ZQ. Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention. J Invasive Cardiol 19: 424-430, 2007. (Pubitemid 47509466)
238. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 342: 276-277, 1993. (Pubitemid 23224422)
239. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 357: 1121-1135, 2007. (Pubitemid 47443217)
240. Yokota S, Furuya M, Seki T, Marumo H, Ohara N, Kato A. Delayed exacerbation of acute myocardial ischemia/reperfusion-induced arrhythmia by tracheal instillation of diesel exhaust particles. Inhal Toxicol 16: 319-331, 2004. (Pubitemid 38581361)
241. Yvon A, Hanouz JL, Haelewyn B, Terrien X, Massetti M, Babatasi G, Khayat A, Ducouret P, Bricard H, Gérard JL. Mechanisms of sevoflurane-induced myocardial preconditioning in isolated human right atria in vitro. Anesthesiology 99: 27-33, 2003. (Pubitemid 36799029)
242. Zaman MB, Leonard MO, Ryan EJ, Nolan NP, Hoti E, Maguire D, Mulcahy H, Traynor O, Taylor CT, Hegarty JE, Geoghegan JG, O'Farrelly C. Lower expression of Nrf2 mRNA in older donor livers: a possible contributor to increased ischemia-reperfusion injury? Transplantation 84: 1272-1278, 2007.
243. Zhang KR, Liu HT, Zhang HF, Zhang QJ, Li QX, Yu QJ, Guo WY, Wang HC, Gao F. Long-term aerobic exercise protects the heart against ischemia/reperfusion injury via PI3 kinase-dependent and Akt-mediated mechanism. Apoptosis 12: 1579-1588, 2007.
244. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285: H579-H588, 2003. (Pubitemid 36885888)